1-3 of 3
Authors: Angel Chen
Sort by
Journal Article
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level Open Access
Erik A Imel and others
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 11, November 2023, Pages 2990–2998, https://doi.org/10.1210/clinem/dgad230
Published: 21 April 2023
Journal Article
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia Open Access
Leanne M Ward and others
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 8, August 2022, Pages e3241–e3253, https://doi.org/10.1210/clinem/dgac296
Published: 09 May 2022
Journal Article
Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia Open Access
Agnès Linglart and others
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 3, March 2022, Pages 813–824, https://doi.org/10.1210/clinem/dgab729
Published: 12 October 2021
Advertisement
Advertisement